Fred Craves, PhD, is the Founder and Managing Director of Bay City Capital. See sector focus and contact routes.
Fred Craves, PhD, is the Founder and Managing Director of Bay City Capital, a San Francisco-based venture firm he launched in 1997 that has invested in nearly 100 life science companies and raised over $1.6 billion. His investment thesis focuses exclusively on the life sciences sector, targeting biopharmaceutical opportunities across all stages of the product lifecycle from discovery through commercialization. While specific check sizes and lead/follow behavior are not publicly detailed, Craves leverages deep operational expertise and a PhD in Pharmacology and Toxicology to support management teams in creating value. Notable portfolio companies include Madrigal Pharmaceuticals, Twist Bioscience, Medarex, and Ion Torrent, alongside his founding of Reliant Pharmaceuticals which was sold to GlaxoSmithKline in 2007. Craves has been named to the Forbes Midas List, recognizing top investors across technology and healthcare, and currently serves on the boards of KBP Biosciences, IMIDomics Inc., Madrigal Pharmaceuticals, and Synchronicity. His distinctive point of view combines scientific rigor with executive leadership, having previously served as CEO of Berlex Biosci
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in San Francisco.
Investors like Fred Craves · Full investor directory · Investor access · Company funding database